Clinical Trial Update: Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)

View source ↗

Summary

This is an update on a completed historical control study (P02387) of patients with invasive fungal infections who are refractory to or intolerant of standard a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infections

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Infection, Invasive Fungal | Status: COMPLETED